Approvals/CIMA-AEMPS/OPDUALAG 240 MG/80 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

OPDUALAG 240 MG/80 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Bristol-Myers Squibb Pharma Eeig🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: dc9fb700369332c3
Drug Cima Aemps Name: OPDUALAG 240 MG/80 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1221679001
Holder Company Name: Bristol-Myers Squibb Pharma Eeig
Marketing Company Name: Bristol Myers Squibb S.A.
Holder Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig
Authorization Date: 2024-01-10
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 240 mg/80 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Bristol-Myers Squibb Pharma Eeig
Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig

RELATLIMAB

85,20 mg

NIVOLUMAB

255,60 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 10, 2024

Approval ID

dc9fb700369332c3

Type

Standard